Profil
Jeffrey Millard is Executive Vice President-Technical Operations at Eupraxia Pharmaceuticals, Inc. starting in 2026.
Formerly, Dr. Millard was Chief Operating Officer at Ensysce Biosciences, Inc. from 2019 to 2026.
Education includes an undergraduate degree from William Marsh Rice University and a doctorate from the University of Arizona.
Postes actifs de Jeffrey Millard
| Sociétés | Poste | Début |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | 13/07/2026 |
Anciens postes connus de Jeffrey Millard
| Sociétés | Poste | Fin |
|---|---|---|
| ENSYSCE BIOSCIENCES, INC. | Directeur des opérations | 10/07/2026 |
Ensysce Biosciences, Inc. /Old/
Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Supplies drugs for pain and cancer markets | Directeur des opérations | - |
Formation de Jeffrey Millard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ensysce Biosciences, Inc. /Old/
Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Supplies drugs for pain and cancer markets | Distribution Services |
Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
















